GALECTIN THERAPEUTICS Trademark

Trademark Overview

On Tuesday, March 12, 2013, a trademark application was filed for GALECTIN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GALECTIN THERAPEUTICS trademark a serial number of 85873512. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, May 13, 2024. This trademark is owned by Galectin Therapeutics Inc.. The GALECTIN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis, fibrosis, inflammatory and autoimmune disorders, neoplastic conditions, cancer, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis
galectin therapeutics

General Information

Serial Number85873512
Word MarkGALECTIN THERAPEUTICS
Filing DateTuesday, March 12, 2013
Status800 - REGISTERED AND RENEWED
Status DateMonday, May 13, 2024
Registration Number4476339
Registration DateTuesday, January 28, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis, fibrosis, inflammatory and autoimmune disorders, neoplastic conditions, cancer, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2013
Primary Code005
First Use Anywhere DateFriday, June 28, 2013
First Use In Commerce DateFriday, June 28, 2013

Trademark Owner History

Party NameGalectin Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorcross, GA 30071
Party NameGalectin Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorcross, GA 30071

Trademark Events

Event DateEvent Description
Monday, June 24, 2013NON-FINAL ACTION WRITTEN
Friday, March 15, 2013NEW APPLICATION ENTERED
Monday, March 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 21, 2013ASSIGNED TO EXAMINER
Monday, June 24, 2013NON-FINAL ACTION E-MAILED
Monday, June 24, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 16, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 3, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 9, 2013ASSIGNED TO LIE
Tuesday, July 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 16, 2013NON-FINAL ACTION WRITTEN
Friday, August 16, 2013NON-FINAL ACTION E-MAILED
Friday, August 16, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 19, 2013ASSIGNED TO LIE
Friday, August 16, 2013EXAMINERS AMENDMENT E-MAILED
Friday, August 16, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 16, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, August 20, 2013TEAS AMENDMENT OF USE RECEIVED
Wednesday, August 21, 2013USE AMENDMENT FILED
Wednesday, August 21, 2013AMENDMENT TO USE PROCESSING COMPLETE
Friday, August 30, 2013USE AMENDMENT ACCEPTED
Saturday, August 31, 2013NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, December 17, 2013APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, January 28, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 3, 2020TEAS SECTION 8 RECEIVED
Wednesday, February 12, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 20, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 28, 2014REGISTERED-SUPPLEMENTAL REGISTER
Monday, December 3, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 3, 2018REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Thursday, February 13, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, February 13, 2020NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, January 28, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, January 26, 2024TEAS SECTION 8 & 9 RECEIVED
Monday, May 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 13, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, May 13, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, May 13, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Related Keywords

therapeutics galectin fibrosis conditions neoplastic cancer liver heart lung kidney disorders inflammatory